Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength

Sponsor
DuPont Nutrition and Health (Industry)
Overall Status
Completed
CT.gov ID
NCT01749189
Collaborator
(none)
58
1
3
23
2.5

Study Details

Study Description

Brief Summary

This study will investigate the effects of a soy/dairy protein blend on muscle growth and strength. In sports nutrition and in aging it is important to have healthy muscles. This can be achieved with exercise and nutrition. Consumption of protein following resistance exercise can promote healthy muscle growth and help improve strength. Young healthy men will be studied during a 12 week resistance exercise training program and be given protein supplements every day during the study. The hypothesis is that a blend of soy, whey and casein will induce a greater muscle gain and strength increase than the control.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Blend
  • Dietary Supplement: Whey
  • Dietary Supplement: Placebo
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
A Randomized, Controlled Double Blind Longitudinal Study: Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo

Placebo dry blended beverage (carbohydrate)

Dietary Supplement: Placebo
22 grams of carbohydrate/day

Experimental: Blend

A dry blended beverage containing a protein blend of soy, whey and casein

Dietary Supplement: Blend
22 grams of protein/day

Active Comparator: Whey

A dry blended beverage containing Whey protein

Dietary Supplement: Whey
22 grams of protein/day

Outcome Measures

Primary Outcome Measures

  1. Change in Muscle Mass [Baseline, 6 weeks, 12 weeks]

    Muscle Mass will be determined by DEXA

Secondary Outcome Measures

  1. Change in Muscle Strength [Baseline, 6 weeks, 12 weeks]

    Knee Extensor

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Stable body weight, healthy, males aged 18-35
Exclusion Criteria:
  1. Exercise training (>2 weekly sessions of moderate to high intensity aerobic or resistance exercise)

  2. Resistance Training (>2 weekly sessions of moderate to high intensity) within the past six months

  3. Any orthopedic injury that prohibits participation in the exercise training

  4. Significant heart, liver, kidney, blood, or respiratory disease

  5. Peripheral vascular disease

  6. Diabetes mellitus or other untreated endocrine disease

  7. Active cancer (all groups) and history of cancer

  8. Acute infectious disease or history of chronic infections (e.g. TB, hepatitis, HIV, herpes)

  9. Recent (within 6 months) treatment with anabolic steroids, or corticosteroids.

  10. Alcohol or drug abuse

  11. Tobacco use (smoking or chewing)

  12. BMI range will be (20-29.9 kg/m2) to exclude for Malnutrition (hypoalbuminemia, and/or hypotransferrinemia) and Obesity

  13. Low hemoglobin levels (below normal values)

  14. Food allergies (including milk and soy)

  15. Individuals on a Vegetarian Diet

  16. Females

  17. Average protein intake < 0.6 or >1.8 g/kg per day

  18. Taking dietary supplements such as green tea, creatine, ribose, whey or soy protein, etc. within the past 6 months

  19. Currently on a high-soy diet or high dairy diet (consuming >2 servings of soy per day or >6 servings of dairy)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas Medical Branch Galveston Texas United States 77555

Sponsors and Collaborators

  • DuPont Nutrition and Health

Investigators

  • Principal Investigator: Blake Rasmussen, PhD, University of Texas
  • Principal Investigator: Mark B Cope, PhD, Solae, LLC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
DuPont Nutrition and Health
ClinicalTrials.gov Identifier:
NCT01749189
Other Study ID Numbers:
  • CRC-D-179
First Posted:
Dec 13, 2012
Last Update Posted:
Oct 7, 2019
Last Verified:
Oct 1, 2019
Keywords provided by DuPont Nutrition and Health

Study Results

No Results Posted as of Oct 7, 2019